We use cookies for a better user experience. Read our Privacy Policy

I Agree

Facial Injectables Market

Facial Injectables Market (Botulinum Toxin, Hyaluronic Acid, Collagen and Polymers and Particles (PPFs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

Worldwide willingness to look younger and maintain youthfulness is rising swiftly. In addition, rising geriatric population globally increases the demand for aesthetic treatment. Increased healthcare spending, improving lifestyle, growth in working population after attaining retirement age and increased preference for minimally invasive surgeries are some of the factors that are driving the growth of global facial injectables market. Since, facial injectable procedure is a minimally invasive procedure and recovery time is lesser as compared to invasive aesthetic procedures such as plastic surgery and face lift surgeries. Thus, less recovery time and minimal invasive procedure are some of the factors that are attracting aged population with weaker immune system to undergo facial injectable treatment. 
 
Global facial Injectables market is broadly segmented as hyaluronic acid, collagen, botulinum toxin and polymers and particle fillers (PPFs). Polymers and particles fillers (PPFs) market is expected to grow at faster rate owing to advantage of prolong longevity of effects and reduced side effects over other facial injectable products (hyaluronic acid, collagen and botox). Presently available facial injectable products are widely used for correction of face namely, lip, glabeller, periorbital, nasolabial, chin and cheeks. Apart from reduction of wrinkles appearing on facial skin, facial injectable products are also used to give volume to cheeks, lip augmentation and for correction of depression occurring due to scars. Currently, hyaluronic acid product segment is dominating the global facial injectables market.
 
Geographically North America dominates the global facial injectables market. Europe facial injectables market is the second largest market after North America in the global facial injectables market. Availability of aged and adult population pool, increasing willingness to look younger and high rate of spending on aesthetic procedures are some of the factors that are driving the growth of facial injectables market in North America. In addition, highly advanced healthcare infrastructure, well structured regulatory guidelines and higher rate of implementation of regulatory guidelines in practice are some of the other factors fueling the growth of the facial injectables market in North America. Asia Pacific facial injectables market is expected to grow at the highest growth rate during the forecast period from 2014 to 2020. Asian countries namely, India and China account for the largest population pool in the world. Therefore, China and India are expected to account for largest pool of geriatric population in the world in near future. Presence of large geriatric population coupled with rising disposable income are some of the key factors augmenting the growth of facial injectables market in Asia Pacific. In addition, rapidly developing healthcare infrastructure and rising healthcare spending are some of the factors that are expected to fuel the growth of the facial injectables market in Asia Pacific. Apart from India and China, South Korea is a lucrative market for facial injectables market owing to rapidly rising aesthetic surgical procedures in the country. 
Facial Injectables Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Facial Injectables Market (2013 and 2020)
2.2 Comparative Analysis: Global Facial Injectbales Market, by Geography, 2013 & 2020 (Value %)
 
Chapter 3 Market Overview
3.1 Overview – Current Market Scenario and Future Market Trends
       3.1.1 Global Facial Injectables Market, by Products, 2012 – 2020 (USD Million)
3.2 Market Drivers
       3.2.1 Increased longevity of the effects is augmenting the demand for facial injectable
       3.2.2 Rising geriatric population is augmenting the demand for facial injectables
       3.2.3 Increasing preference for minimally procedures fueling the growth of facial injectable market
3.3 Market Restraints
       3.3.1 Side effects of available products are limiting the adoption
3.4 Opportunities
       3.4.1 Product innovation and process development to overcome disadvantages of commercially available products
3.5 Porter’s Five Force Analysis for the Global Facial Injectable Market
       3.5.1 Bargaining power of suppliers
       3.5.2 Bargaining power of buyers
       3.5.3 Threat of new entrants
       3.5.4 Threat of substitutes
       3.5.5 Competitive Rivalry
       3.5.6 Market Activeness Analysis of Global Facial Injectable Market, by Geography, 2013
3.6 Value Chain Analysis: Global Facial Injectables Market
3.7 Average Selling Price Analysis: Global Facial Injectable Market
3.8 Market Share Analysis: Global Facial Injectables Market, by Key Players, 2013 (Value %)
 
Chapter 4 Global Facial Injectables Market, by Product Type
4.1 Overview – Current Market Scenario and Future Market Trends
       4.1.1 Global Facial Injectables Market, by Products, 2012 – 2020 (USD Million)
       4.1.2 Comparative Analysis: Global Facial Injectables Market, By Product, 2013 & 2020 (Value %)
4.2 Botulinum Toxin
       4.2.1 Global Botulinum Toxin Market Revenue, 2012 – 2020, (USD Million)
4.3 Hyaluronic Acid
       4.3.1 Global Hyaluronic Acid Market Revenue, 2012 – 2020, (USD Million)
4.4 Collagen
       4.4.1 Global Collagen Market Revenue, 2012 – 2020, (USD Million)
4.5 Particles and Polymers Fillers (PPF)
       4.5.1 Global Particles and Polymer Fillers Market Revenue, by Types, 2012 – 2020, (USD Million)
       4.5.2 Polymethylmethacrylate beads (PMMA microspheres)
               4.5.2.1 Global Polymethylmethacrylate beads (PMMA microspheres)Market Revenue, 2012 – 2020, (USD Million)
       4.5.3 Poly-L-lactic acid
                4.5.3.1 Global Poly-L-lactic acid Market Revenue, 2012 – 2020, (USD Million)
       4.5.4 Calcium hydroxyapatite
               4.5.4.1 Global Calcium Hydroxyapatite Market Revenue, 2012 – 2020, (USD Million)
 
Chapter 5 Global Facial Injectables Market, by Geography
5.1 Overview – Current Market Scenario and Future Market Trends
       5.1.1 Global Facial Injectables Market, by Geography, 2012 – 2020 (USD Million)
5.2 North America
       5.2.1 North America Facial Injectables Market, By Product Type, 2012 - 2020 (USD Million)
5.3 Europe
       5.3.1 Europe Facial Injectables Market, by Product Type 2012 – 2020 (USD Million)
5.4 Asia-Pacific
       5.4.1 Asia Pacific Facial Injectables Market, by Product Type 2012 – 2020 (USD Million)
5.5 Rest of the World (RoW)
       5.5.1 RoW Facial Injectables Market, by Product Type 2012 – 2020 (USD Million)
 
Chapter 6 Recommendations
6.1 Research and development initiatives
6.2 International players should establish partnership with local professional/organization to expand their business
 
Chapter 7 Company Profiles
7.1.1 Company Overview
       7.1.2 Financial Overview
       7.1.3 Product Portfolio
       7.1.4 Business Strategies
       7.1.5 Recent Developments
7.2 Bloomage BioTechnology Corporation Limited
       7.2.1 Company Overview
       7.2.2 Financial Overview
       7.2.3 Product Portfolio
7.3 Galderma S.A.
       7.3.1 Company Overview
       7.3.2 Financial Overview
       7.3.3 Product Portfolio
       7.3.4 Business Strategies
       7.3.5 Recent Developments
7.4 Ipsen Group
       7.4.1 Company Overview
       7.4.2 Financial Overview
       7.4.3 Product Portfolio
       7.4.4 Business Strategies
       7.4.5 Recent Developments
7.5 Merz Pharma GmbH & Co. KGaA
       7.5.1 Company Overview
       7.5.2 Financial Overview
       7.5.3 Product Portfolio
       7.5.4 Business Strategies
       7.5.5 Recent Developments
List of Tables
 
TABLE 1 Market Snapshot: Global Facial Injectables Market (2013 and 2020)
TABLE 2 Global Facial Injectables Market Revenue, by Products, 2012 – 2020 (USD Million)
TABLE 3 Global Facial Injectbales Market Revenue, by Products, 2012 – 2020 (USD Million)
TABLE 4 Global Facial Injectables Market Revenues, by Geography, Size and Forecast, 2012 - 2020 (USD Million)
TABLE 5 North America Facial Injectables Market, by Product Type, 2012 - 2020 (USD Million)
TABLE 6 Europe Facial Injectables Market, by Product Type, 2012 - 2020 (USD Million)
TABLE 7 Asia Pacific Facial Injectables Market, by Product Type, 2012 - 2020 (USD Million)
TABLE 8 RoW Facial Injectables Market, by Product Type, 2012 - 2020 (USD Million)

List of Figures

 

FIG. 1 Market Segmentation: Global Facial Injectables Market

FIG. 2 Global Facial Injectables Market Revenue, by Product, 2013 (USD Million)

FIG. 3 Comparative Analysis: Global Facial Injectables Market, by Geography, 2013 & 2020 (Value %)

FIG. 4 Porter’s Five Force Analysis: Global Facial Injectables Market

FIG. 5 Market Attractiveness Analysis: Global Facial Injectables Market, by Geography

FIG. 6 Value Chain Analysis: Global Facial Injectables Market

FIG. 7 Market Share Analysis: Global Facial Injectables Market, by Key Players, 2013 (Value %)

FIG. 8 Comparative Analysis: Global Facial Injectables Market, by Products, 2013 & 2020 (Value %)

FIG. 9 Global Botulinum Toxin Market Revenue, 2012 – 2020, (USD Million)

FIG. 10 Global Hyaluronic Acid Market Revenue, 2012 – 2020, (USD Million)

FIG. 11 Global Collagen Market Revenue, 2012 – 2020, (USD Million)

FIG. 12 Global Particles and Polymer Fillers  Market Revenue, 2012 – 2020, (USD Million)

FIG. 13 Global Polymethylmethacrylate beads (PMMA microspheres)Market Revenue, 2012 – 2020, (USD Million)

FIG. 14 Global Poly-L-lactic acid Market  Revenue, 2012 – 2020, (USD Million)

FIG. 15 Global Calcium Hydroxyapatite Market Revenue, 2012 – 2020, (USD Million)

FIG. 16 Allergan, Inc.: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 17 Bloomage BioTechnology Corporation Limited: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 18 Galderma S.A.: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 19 Ipsen Group: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 20 Merz GmbH & Co. KGaA: Annual Revenue, 2011 – 2013 (USD Million)

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

832

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved